High rate of post-therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study
- 作者U. Peitz; M. Sulliga; K. Wolle; A. Leodolter; U. Von Arnim; S. Kahl; M. Stolte; G. Börsch; J. Labenz; P. Malfertheiner
- 卷第16卷
- 期第2期
- 印刷ISSN0269-2813
- 电子ISSN1365-2036
- 文件大小91.50KB
- 发表时间2002
- DOI10.1046/j.1365-2036.2002.01173.x
- 页码315-324
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut · 1997
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportMalfertheiner, P; Megraud, F; O'Morain, C; Bazzoli, F; El-Omar, E; Graham, D; Hunt, R; Rokkas, T; Vakil, N; Kuipers, E J · Gut · 2007
Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus ReportMalfertheiner, P.; Mégraud, F.; OʼMorain, C.; Bell, D.; Porro, Bianchi G.; Deltenre, M.; Forman, D.; Gasbarrini, G.; Jaup, B.; Misiewicz, J. J.; Pajares, J.; Quina, M.; Rauws, E. · European Journal of Gastroenterology & Hepatology · 1997
[Progress in Basic and Clinical Pharmacology] Clinical Pharmacology and Therapy of Helicobacter pylori Infection Volume 11 || Current Concepts in the Management of <i>Helicobacter pylori</i> Infection - The Maastricht 2-2000 Consensus Report (Updated Contents)Scarpignato, C.; Bianchi Porro, G. · 2004